A SERVICE
ANNOUNCEMENT FROM:
|
|
|
|
|
|
|
|
 |
| |
| Website | Data Sheet | Upcoming Event |
| |
Since you have to do it, why not do it right?
Pharsight: Your Partner for High-Quality, Timely PK/PD Study Analysis and Reporting
Pharsight, the maker of Phoenix® WinNonlin®, provides best-in-class PK/PD analysis, biostatistics and regulatory reporting services that are the backbone of every regulatory submission package. Equipped with Pharsight's own leading software and data management tools, we are your global partner for on-time, on-budget, on-target study analysis and reporting from preclinical through Phase IV.
Website:
Pharsight Team Profile, Experience and Approach available at:
http://www.pharsight.com/services/ras_who.php
Data Sheet:
Benefits of Combining PK/PD Expertise and Technology for New Drug Approval
Download Capabilities Summary
Upcoming Event:
Turning PK/PD Data into Knowledge in Non-Clinical and Clinical Studies
Featured Speaker: Jean-Francois Marier, PhD., FCP, Lead Scientist, Pharsight
Register to Attend May 11 Oncology Biomarker Symposium - Montreal, Quebec
Company Contact
321 East Evelyn Avenue, 3rd Floor
Mountain View, CA 94041-1530
Tel: 650.314.3800
Fax: 650.314.381 |
|
|
If you no longer wish to receive emails from Pharsight, Please reply HERE
ACT is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser.
|
|
